This bill aims to regulate the provision of pharmaceutical services in nursing homes by codifying existing Department of Health regulations and introducing measures to prevent conflicts of interest. It mandates that each nursing home must have a consultant pharmacist and either a provider pharmacist or a director of pharmaceutical services if the facility operates an in-house pharmacy. The bill specifies that a New Jersey licensed pharmacist must fulfill these roles and adhere to all relevant federal and state laws and standards of practice.

Additionally, the bill establishes the requirement for each nursing home to form an interdisciplinary pharmacy and therapeutics committee, which must include the facility's administrator, a nursing staff representative, and the consultant pharmacist, with oversight from the medical director as needed. This committee is required to meet at least quarterly and maintain records of its activities. Furthermore, the bill stipulates that the consultant pharmacist must not hold the position of director of pharmaceutical services or pharmacist provider and must attest to having no affiliations with these roles to avoid conflicts of interest.